- $4.81bn
- $5.71bn
- $2.19bn
- 70
- 46
- 98
- 82
R2019 September 30th | R2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,148 | 2,016 | 2,111 | 2,391 | 2,191 |
Cost of Revenue | |||||
Gross Profit | 651 | 599 | 670 | 830 | 668 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,072 | 2,537 | 1,934 | 2,080 | 2,019 |
Operating Profit | 76 | -521 | 177 | 311 | 172 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -9 | -577 | 135 | 206 | 160 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10 | -555 | 173 | 181 | 168 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 505 | -508 | 220 | 927 | 178 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 505 | -508 | 220 | 927 | 178 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.688 | -1.29 | 3.65 | 3.17 | 3.69 |
Dividends per Share |